BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 26592368)

  • 1. Cascade plasmapheresis as preconditioning regimen for ABO-incompatible renal transplantation: a single-center experience.
    Jha PK; Tiwari AK; Bansal SB; Sethi SK; Ahlawat R; Kher V
    Transfusion; 2016 Apr; 56(4):956-61. PubMed ID: 26592368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
    Han S; Hwang E; Park S; Park U; Kim H; Cho W
    Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic apheresis in ABO-incompatible kidney and liver transplantation: A single-center experience of 50 patients.
    Pandey P; Setya D; Sinha V; Bhatt A; Devra A; Chaudhary A; Ranjan S; Srivastava R; Kumar P; Singh MK
    Ther Apher Dial; 2021 Feb; 25(1):103-117. PubMed ID: 32266793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis as preconditioning protocol in an extremely high titer ABO incompatible renal transplant (ABOiRTx) case: A new prospect for chronic kidney disease patients in India.
    Pandey P; Tiwari AK; Sharma J; Dixit S; Raina V
    Transfus Apher Sci; 2013 Aug; 49(1):84-6. PubMed ID: 23845506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological and Extended Clinical Outcomes After ABO-Incompatible Renal Transplantation Without Splenectomy or Rituximab.
    Chow KV; Flint SM; Shen A; Landgren A; Finlay M; Murugasu A; Masterson R; Hughes P; Cohney SJ
    Transplantation; 2017 Jun; 101(6):1433-1440. PubMed ID: 27495772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of ABO-Incompatible Living Donor Renal Transplantations: A Single-Center Experience From Eastern India.
    Ray DS; Thukral S
    Transplant Proc; 2016 Oct; 48(8):2622-2628. PubMed ID: 27788792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO-incompatible pediatric kidney transplantation without antibody removal.
    Kawamura T; Hamasaki Y; Takahashi Y; Hashimoto J; Kubota M; Muramatu M; Itabashi Y; Hyodo Y; Ohashi Y; Aikawa A; Sakai K; Shishido S
    Pediatr Nephrol; 2020 Jan; 35(1):95-102. PubMed ID: 31673829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-filtration plasmapheresis.
    Tanabe K
    Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
    Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
    Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization with the Use of an Antibody Removal-Free Protocol in ABO-Incompatible Kidney Transplant Recipients with a Low Anti-A/B Antibody Titer.
    Nanmoku K; Shinzato T; Kubo T; Shimizu T; Kimura T; Yagisawa T
    Transplant Proc; 2018 May; 50(4):982-986. PubMed ID: 29731097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Transplantation in ABO- and HLA-Incompatible Living Kidney Transplant Patients: A Report on 12 Cases.
    Rostaing L; Karam B; Congy-Jolivet N; Hage V; Sallusto F; Esposito L; Doumerc N; Debiol B; Guilbeau-Frugier C; Game X; Allal A; Kamar N
    Ther Apher Dial; 2016 Oct; 20(5):507-516. PubMed ID: 27073167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Desensitization Allows Pediatric Blood Group Incompatible Kidney Transplantation.
    Stojanovic J; Adamusiak A; Kessaris N; Chandak P; Ahmed Z; Sebire NJ; Walsh G; Jones HE; Marks SD; Mamode N
    Transplantation; 2017 Jun; 101(6):1242-1246. PubMed ID: 27463537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption.
    Becker LE; Siebert D; Süsal C; Opelz G; Leo A; Waldherr R; Macher-Goeppinger S; Schemmer P; Schaefer SM; Klein K; Beimler J; Zeier M; Schwenger V; Morath C
    Transplantation; 2015 Nov; 99(11):2364-71. PubMed ID: 25989497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid accomodation of an A1 renal allograft after preconditioning for ABO-incompatible transplantation.
    Allen G; Simpkins CE; Segev D; Warren D; King K; Taube J; Locke J; Baldwin W; Haas M; Chivukula R; Montgomery RA
    Contrib Nephrol; 2009; 162():35-46. PubMed ID: 19001812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful ABO incompatible renal transplantation following rituximab and DFPP after failed immunoadsorption.
    Thalgahagoda S; Webb NJ; Roberts D; Birch A; Milford DV; Tavakoli A; Shenoy M
    Pediatr Transplant; 2014 May; 18(3):E74-6. PubMed ID: 24483150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning Therapy in ABO-Incompatible Living Kidney Transplantation: A Systematic Review and Meta-Analysis.
    Lo P; Sharma A; Craig JC; Wyburn K; Lim W; Chapman JR; Palmer SC; Strippoli GF; Wong G
    Transplantation; 2016 Apr; 100(4):933-42. PubMed ID: 26425876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of 2 Doses of Rituximab on B-Cell and Antidonor Antibody and Outcomes of ABO-Incompatible Living-Donor Pediatric Kidney Transplant.
    Hamasaki Y; Aikawa A; Itabashi Y; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Kawamura T; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):105-109. PubMed ID: 30777532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation.
    Takahashi K; Saito K; Takahara S; Fuchinoue S; Yagisawa T; Aikawa A; Watarai Y; Yoshimura N; Tanabe K; Morozumi K; Shimazu M;
    Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience.
    Donauer J; Wilpert J; Geyer M; Schwertfeger E; Kirste G; Drognitz O; Walz G; Pisarski P
    Xenotransplantation; 2006 Mar; 13(2):108-10. PubMed ID: 16623802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
    Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P
    Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.